cariporide has been researched along with Liver Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bendia, E; Benedetti, A; Candelaresi, C; Di Sario, A; Kleemann, HW; Macarri, G; Marzioni, M; Pigini, P; Schindler, U; Taffetani, S; Trozzi, L | 1 |
| Caligiuri, A; De Franco, RM; Failli, P; Geerts, A; Gentilini, A; Gentilini, P; Marra, F; Mazzetti, L; Meucci, M; Pinzani, M; Romanelli, RG; Rombouts, K; Vanasia, M | 1 |
2 other study(ies) available for cariporide and Liver Cirrhosis
| Article | Year |
|---|---|
Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat.
Topics: Animals; Bile Ducts; Cell Division; Cells, Cultured; Dimethylnitrosamine; Enzyme Activation; Guanidines; Ligation; Liver; Liver Cirrhosis; Male; Mitogen-Activated Protein Kinases; Phosphorylation; Platelet-Derived Growth Factor; Protein Kinase C; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; Sodium-Hydrogen Exchangers; Sulfones | 2003 |
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells.
Topics: Aldosterone; Amiloride; Calcium; Canrenone; Cell Division; Cell Movement; Cells, Cultured; Extracellular Matrix Proteins; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Guanidines; Humans; Hydrogen-Ion Concentration; Intracellular Membranes; Liver; Liver Cirrhosis; Mineralocorticoid Receptor Antagonists; Phosphatidylinositol 3-Kinases; Phosphorylation; Platelet-Derived Growth Factor; Protein-Tyrosine Kinases; Signal Transduction; Sodium-Hydrogen Exchangers; Sulfones; Thrombin | 2003 |